Establishment of comprehensive geriatric assessment based multidisciplinary team approach for hospitalized frail patients
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Registration Number
- KCT0006270
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1040
1. Patients 65 years of age or older who are hospitalized or scheduled to be hospitalized due to acute illness.
2. Patients categorized to Frail or Prefrail assessed by Korean version of the Fatigue, Resilience, Ambulation, Illness and Loss of Weight scale (K-FRAIL)
3. Patients having two or more of the following diseases (hypertension, diabetes, ischemic heart disease, chronic lung disease, arthritis, stroke, depression, chronic kidney disease, dementia)
4. Patient who are living at home for more than 3 months before hospitalisation.
5. (For substudy 3 only) Patients who subject to conventional primary chemotherapy because local treatment for curative purposes (such as surgery, concurrent chemoradiotherapy, radiation therapy, etc.) is ineligible (stage stage 3 or higher)
6. (For substudy 3 only) Patients confirmed histologically as cancer (gastric adenocarcinoma, colon adenocarcinoma, non-small cell and small cell lung cancer, pancreatic adenocarcinoma, biliary adenocarcinoma)
1. Patients who planned hospitalisation in the specialised care unit, such as an intensive care unit and/or acute stroke ward, at the time of admission
2. Patients whose stage is terminal requiring hospice or palliative care.
3. Life expectancy is less than 6 months
4. Serious conditions that limit the participation in the research
5. (For substudy 3 only) Patients who planned to use oral targeted therapy as a palliative first-line chemotherapy
6. (For substudy 3 only)) Patients who recur within 6 months after completion of adjuvant chemotherapy.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method